If endogenous prolactin secretion is important in normal development of fetal lung surfactant, the inhibition of its secretion should be associatedwith delayed maturation of fetal lung.
Summary
If endogenous prolactin secretion is important in normal development of fetal lung surfactant, the inhibition of its secretion should be associatedwith delayed maturation of fetal lung.
We therefore studied the effect of bromoergocriptine administration to pregnant rabbits upon lecithin content of fetal lung washes.
The does were treated since the 27th day of gestation with either Mesilate of 2-Bromo-a-ergocriptine (C32H.,0BrN~05. CH3S03H) (Bromocriptine) (Parlodel, Sandoz) (1 mg/kg/day) or solvent twice daily until delivery.
The newborns were killed immediately by intraperitoneal administration of sodium penthobarbital and tracheostomized; then lung washes were performed.
The extracted lipids were plated and run on heat-activated thin layers of silica gel H. Lecithin was eluted, and phosphorus determination was performed.
The level of lecithin phosphorus in the lung washes of the fetuses whose mothers received Bromocriptine was x = 2.24 + 0.39 pg/g dry lung weight, whereas that of fetuses of control does was x = 6.93 + 2.64 pg/g dry lung weight ( P < 0.001).
The mean body weight of the fetuses from treated mothers was 38.22 + 6.39 g whereas that of fetuses from control rabbits was 47.63 + 6.94 g ( P < 0.001).
The mother's body weight gain from days 26 to 30 in Bromocriptine-treated rabbits was 156.11 + 99.4 g, whereas that of controls was 374.38 f 166.21 g (P < 0.01).
Speculation
Prolactin could be involved in the normal biochemical develop ment of the lung and also be necessary for a normal weight gain of mother and fetuses during the last stage of gestation.
Biochemical maturation of the fetal lung as revealed by an increase in lecithin production occurs towards the end of gestation.
This process is influenced by the administration of hormones such as glucocorticoids (7, 8) , thyroxine (24) , estrogens (16) , and prolactin (14) . Also, it has been shown that insulin (19) , epidermal growth factor (4) . /3-adrenergic agents (25) , and cholinergic drugs (5) could affect lung maturation.
Recently, it has been shown that there is a relationship between cord prolactin levels and respiratory distress syndrome incidence (e.g., low cord prolactin is associated with high incidence of this syndrome) (1 1, 12, 15,21,22) . This observation would suggest that endogenous prolactin could be involved in the process of lung maturation.
In this study, we postulated that if endogenous prolactin secretion is important in normal development of fetal lung surfactant, the inhibition of its secretion should be associated with delayed maturation of fetal lung.
MATERIALS AND METHODS
Time dated pregnant Californian rabbits (eight controls and nine bromocriptine treated) were used in this study.
They were mated between 10 AM and 2 PM, and this day was taken as day 0 of gestation. The rabbits were fed ad libitum with water and rabbit food.
The does were treated since the 27th day of gestation with either Bromocriptine (Parlodel, Sandoz) (I mg/kg/day) or solvent twice daily until delivery. Delivery was performed by hysterotomy on day 30 of gestation.
The newborns were killed immediately by intraperitoneal administration of sodium penthobarbital before amniotic sac rupture and weighed. They were exsanguinated by cutting the abdominal aorta, and tracheotomy was performed in five of them. Once tracheostomized, lung washes were performed as previously described (3) .
Briefly, each pair of lungs was gently lavaged with 2 ml of 0.9% saline solution (20°C) five times. The washings were pooled by litter groups. After the lavages, the lungs were dried in a desiccator at 100°C until their weight was constant.
The alveolar washes were stirred with an equal volume of methanol and lipids extracted with two volumes of chloroform (10) .
The extracted lipids were plated and run on heat-activated thin layers of silica gel H containing 5% ammonium sulphate. The plates were developed using chloroform-methanol-acetic acidHz0 (390-150-48-24 p/p).
After development of the chromatograms, the plates were charred at 280°C for 10 min to visualize compounds. Lecithin was eluted, and phosphorus determination was performed by the method of Bartlett (2) . The statistical analysis was done by the t test.
RESULTS
The lecithin phosphorus concentrations in lung washes of both groups are shown in Figure 1 . The level of lecithin phosphorus in the lung washes of the fetuses whose mothers received Bromocriptine was R = 2.24 -+ 0.39 pg/g dry lung weight, whereas that of fetuses of control does was X = 6.93 -t 2.64 pg/g dry lung weight.
The difference was statistically significant (P < 0.001).
It was also observed that Bromocriptine administration caused a reduction in body weight of the fetuses and in the weight gain of the does (Table 1) .
The mean body weight of the fetuses from treated mothers was 38.22 -t 6.39 g whereas that of fetuses from control rabbits was 47.63 + 6.94 g.
The t test showed that the difference was statistically significant (P < 0.001).
The mother body weight gain from days 26 to 30 was significantly lower in the treated animals. The mean body weight gain in Bromocriptine-treated rabbits was 156.11 f 99.4 g whereas that of controls was 374.38 f 166.21 g. The t test showed that this difference was statistically significant (P < 0.01).
There were no differences in the does body weight at the 26th day and in the litter size of both groups of animals (Table I) .
DISCUSSION
Many hormones affect lecithin production by the fetal lung. There are conflictive reports about the effect of prolactin. Hamosh and Hamosh (14) reported that 1 mg of purified ovine prolactin administered intramuscularly to fetal rabbits on day 24th of gestation resulted in an increase of 67% in lung dipalmitoylphosphatidylcholine 48 hr later. This result could not be confirmed by the experiments in rabbits and sheep performed by Ballard et al. ( I ) using a similar scheme. Also, it was reported that the administration of 1.0 mg intramuscular prolactin on the 24th day to fetal rabbits did not modify the pressure-volume relationship of the lung analyzed 2 days later (23) .
On the other hand, Cox and Torday (6) have shown that the presence of 10 pg/ml of ovine prolactin (Sigma Chemical Co.) Clinical studies seem to support the concept that prolactin could be a physiologic inducer of lecithin production by the fetal lung. Several workers (1 1, 12, 15, 2 1, 22 ) reported lower levels of cord prolactin in premature newborns that developed respiratory distress syndrome as compared with premature infants that did not develop this syndrome.
In our study, the administration of bromoergocriptine on days 27 to 29 of gestation to pregnant rabbits, was associated with lower lecithin concentration in fetal lung washes performed at the 30th day of gestation. These results agree with those obtained by Mullon et al. ( 18) .
Although we know that bromoergocriptine could have some vascular effects (9), we assume that these effects could not significantly modify lung lecithin production.
The reduction in lecithin content in lung washes observed after the administration of bromoergocriptine may be related to the inhibition of prolactin release, since in sheep it has been shown that bromoergocriptine could decrease prolactin secretion in the fetus (13) .
The weight of the fetuses from treated rabbits was lower than that of the control group; this reduced weight might be partially responsible for the decrease in maternal weight gain of our treated does. Also. it is well known that prolactin is involved in the control of lipid metabolism (17) . Therefore, by reducing fat content. this could partially respond for the decreased maternal and fetal weights. -Further observations (i.e., maternal and fetal prolactin levels and fetal adrenal function) are necessary to elucidate the mechanism of action of bromoergocriptine in lecithin production by the fetal lung.
